Gs Investments Inc. lifted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 3.3% during the 1st quarter, HoldingsChannel.com reports. The fund owned 9,569 shares of the company’s stock after acquiring an additional 305 shares during the period. Gs Investments Inc.’s holdings in Henry Schein were worth $575,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Headinvest LLC increased its holdings in Henry Schein by 100.0% in the 4th quarter. Headinvest LLC now owns 13,160 shares of the company’s stock valued at $1,033,000 after purchasing an additional 6,580 shares during the last quarter. Royal London Asset Management Ltd. lifted its stake in shares of Henry Schein by 81.5% in the fourth quarter. Royal London Asset Management Ltd. now owns 154,591 shares of the company’s stock worth $12,046,000 after buying an additional 69,421 shares during the last quarter. Steinberg Global Asset Management lifted its stake in shares of Henry Schein by 43.4% in the fourth quarter. Steinberg Global Asset Management now owns 32,661 shares of the company’s stock worth $2,565,000 after buying an additional 9,879 shares during the last quarter. JLB & Associates Inc. lifted its stake in shares of Henry Schein by 2.7% in the fourth quarter. JLB & Associates Inc. now owns 57,301 shares of the company’s stock worth $4,499,000 after buying an additional 1,483 shares during the last quarter. Finally, Bell Rock Capital LLC acquired a new stake in shares of Henry Schein in the first quarter worth $581,000.
A number of equities analysts recently issued reports on HSIC shares. BidaskClub raised shares of Henry Schein from a “buy” rating to a “strong-buy” rating in a research report on Thursday, December 27th. Robert W. Baird lowered shares of Henry Schein from an “outperform” rating to a “neutral” rating and set a $76.60 target price on the stock. in a research report on Wednesday, January 2nd. ValuEngine raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Wednesday, January 2nd. Evercore ISI lowered shares of Henry Schein from an “in-line” rating to an “underperform” rating and set a $76.39 target price on the stock. in a research report on Thursday, January 3rd. Finally, Zacks Investment Research lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Tuesday, January 8th. Six research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $77.57.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Wednesday, February 20th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.01. The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.46 billion. Henry Schein had a net margin of 4.06% and a return on equity of 19.86%. The business’s revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.97 EPS. Analysts predict that Henry Schein, Inc. will post 3.43 earnings per share for the current fiscal year.
In other Henry Schein news, Director Philip A. Laskawy sold 1,084 shares of the business’s stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $59.86, for a total value of $64,888.24. Following the sale, the director now owns 32,899 shares of the company’s stock, valued at approximately $1,969,334.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.15% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Gs Investments Inc. Grows Position in Henry Schein, Inc. (HSIC)” was reported by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/26/gs-investments-inc-grows-position-in-henry-schein-inc-hsic.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More: What is a Fiduciary?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.